STUDY QUESTION: Is there a difference in pregnancy rates between embryos transferred electively on Day 5 and Day 6, respectively?
Introduction
Optimal embryo culture and laboratory procedures are fundamental for a successful IVF programme. Improvements in culture media, focus on quality control and better incubators have gradually enabled prolonged culture of human embryos to the blastocyst stage (Lane and Gardner, 2007; Smith et al., 2012a Smith et al., , 2012b . As summarized in a recent Cochrane review, where clinical outcome of blastocyst stage (Days 5-6) embryo transfers was compared with cleavage stage (Days 2-3) embryo transfers, fresh blastocyst stage transfer is associated with higher rates than fresh cleavage stage transfer (Glujovsky et al., 2016) . Consequently, there has been a gradual shift from the initial standard procedure of cleavage stage embryo transfer on Day 2 or 3 towards blastocyst transfer on Day 5 or 6. Whether embryo transfer on Day 5 and on Day 6 yields similar pregnancy rates remains, however, to be investigated. Although several studies have raised concern that Day 6 transfer have lower implantation rates (IRs) compared with Day 5 transfers (Schoolcraft et al., 1999; Khorram et al., 2000; Shapiro et al., 2001; Barrenetxea et al., 2005; Dessolle et al., 2011) , these studies were based on non-elective Day 6 transfers, where transfer was postponed to Day 6 due to developmentally delayed embryos. The relatively lower IRs have therefore traditionally been explained by lower quality of the transferred embryos, as blastocoel expansion is positively correlated to subsequent implantation (Alpha Scientists, 2011) . Transfer in fresh cycles on Day 6 is therefore still performed systematically in clinics for logistical reasons, for example limited opening hours or while awaiting PGS/PGD results. However, an alternative and plausible explanation to the observed lower pregnancy rates after Day 6 is asynchrony between embryo development and the stimulated endometrium, which is supported by comparable pregnancy rates of cryopreserved blastocysts regardless of developmental speed before cryopreservation (Sunkara et al., 2010) . If so, fresh transfer on Day 6 should be avoided. A change in standard laboratory procedures towards cryopreservation after Day 5 is readily achievable, if the hypothesis of endometrial asynchrony as a major contributor to the reduced pregnancy rates after Day 6 transfer can be strengthened, and could potentially have major impact on success rates. To do so, it is necessary to compare outcome after transfer on Days 5 and 6 of embryos that have similar quality on Day 5. However, no larger studies have compared elective single blastocyst transfers on Day 5 with Day 6. The aim of the present study was therefore to identify any difference in pregnancy rates of normally developing blastocysts to either elective Day 5 transfers or elective Day 6 transfers in fresh cycles.
Materials and methods

Study design and participants
The study was designed as a retrospective observational follow-up study. No institutional review board (IRB) approval was required for the data retrieval, as the purpose of the study was to evaluate the standard treatment applied according to the clinics guidelines. Data from infertile patients receiving embryo blastocyst transfer on Day 5 or Day 6 at the Fertility Clinic, Aarhus University Hospital were collected retrospectively from February 2011 until August 2015. From February 2011 till August 2013, blastocyst transfers were offered only to patients as part of a study protocol approved by The Central Denmark Region Committees on Biomedical Research Ethics and the Danish Data Protection Agency (Kirkegaard et al., , 2014 Sundvall et al., 2013) . Blastocysts were transferred on Day 6 according to the protocol. If Day 6 fell on a Sunday, patients received Day 5 blastocyst transfer (Fig. 1) . From August 2013 and forward, blastocyst transfer was routinely offered to all patients with ≥six oocytes retrieved. Routinely, blastocysts were transferred on Day 5. However, if Day 5 fell on a Sunday, the transfer was delayed to Day 6 (Fig. 1) . Thus, patients would receive transfer on Day 5 or Day 6 by chance according to day of week. Data retrieval was restricted to include patients aged <38 years, with ≥eight oocytes retrieved and no diagnosis of endometriosis. Furthermore, we restricted the data analysis to single embryo transfers only. Patients could contribute to the study with one treatment cycle only. Patients undergoing pre-implantation genetic diagnosis and patients receiving non-elective Day 6 transfer due to delayed development were excluded from the analysis. Data related to patient characteristics (age, BMI, cumulative FSH dose and number of cryopreserved embryos) were obtained for the treatment cycle analysis. Causes of infertility were categorized into female or male factor and unexplained. We identified 336 single elective Day 5 transfers and 269 elective Day 6 transfers. Due to missing data on clinical outcome, three patients were excluded, which left 334 single elective Day 5 transfers and 268 elective Day 6 for the data analysis.
Ovarian stimulation, oocyte retrieval, IVF and embryo culture
Patients underwent ovarian stimulation in either a long downregulation protocol or a short antagonist protocol using urinary or recombinant FSH stimulation according to the guidelines of the clinic (Kirkegaard et al., 2012) . FSH doses were adjusted individually to the patient's ovarian response. A dose of 10 000 IU of hCG was administered when at least three follicles measured ≥17 mm and ultrasound guided oocyte retrieval was conducted 36 h later. Insemination was performed using standard IVF or ICSI procedures according to treatment indications. All embryos were cultured in sequential culture medium (Sydney IVF Fertilization/Cleavage/ 
Embryo transfer
Blastocysts were graded according to the Gardner criteria; in brief based on expansion of the blastocoel cavity (1-6), number and cohesiveness of the inner cell mass (ICM) and trophectoderm (TE) (A-C) (Gardner et al., 2004) . The embryo with the highest score was selected for transfer on the morning of either Day 5 or Day 6, according to the day of week as described above. For the purpose of this study, Day 5 blastocysts were grouped as low (BS 1, 2 and <3BB), medium (≥3BB/AB/BA) or high quality (≥3AA). Similarly, Day 6 blastocysts were grouped as low (BS 1, 2 and <4BB), medium (≥4BB/AB/BA) or high quality (≥4AA). Biochemical pregnancy was confirmed by serum β-hCG measurement 16 days after oocyte retrieval. Clinical pregnancy was registered based on the presence of foetal heart beat visualized by ultrasound 5 weeks after embryo transfer.
Sample size calculation and statistical analysis
The main outcome was clinical pregnancy, which in this study equals IR, as only single embryo transfers were included. A previous study comparing Day 5 with Day 6 reported a reduction in IR rate from 40 to 20% if transfer was performed on Day 6 (Dessolle et al., 2011) . Post hoc powercalculations based on a two-sided level of significance at 0.05 with a power of 80 indicate that 91 embryos were needed in each group to detect a reduction in IR rate from 40 to 20%. Univariable logistic regression analysis was performed to identify potential confounders on the primary outcome. Factors with a P-value of <0.1 were subsequently included in the multivariable logistic regression analysis investigating the effect of day of transfer on the clinical pregnancy rate. All statistical analyses were performed in the statistical package STATA for Mac, version 14.0 (StataCorp, USA). Two-sided P-values <0.05 were considered significant.
Results
We included 334 elective Day 5 and 268 elective Day 6 single blastocyst transfers in the data analysis. Patient and cycle characteristics compared by day of transfer are summarized in Table I . As expected patients who received transfer on D6 constituted 6/7 of total transfers in the first period and 1/7 in the last period (Fig. 1) . Conversely, patients who received transfer on D5 constituted 1/7 of total transfers in the first period and 6/7 in the last period, suggesting that day of transfer was allocated by chance according to day of the week as expected. There were no differences in patient characteristics between the two groups with regard to age, BMI, cumulative FSH dose, number of aspirated oocytes and fertilization method. Patients in the Day 5 group were more often in their first treatment cycle compared with patients in the Day 6 group. Furthermore, there were significant differences between embryo score on the day of transfer and cycle outcome between the two groups. As expected embryos from Day 6 patients had a significantly higher degree of expansion compared with embryos from Day 5 (3.7 ± 0.67 vs. 5.0 ± 0.80), as they were incubated for 24 h more. Unexpectedly, a significantly higher percentage of embryos from patients in the Day 6 group received a 'C' score of the ICM (7.1 vs. 1.0%) and TE (8.6 vs. 0.65%) compared with embryos from patients in the Day 5 group. Conversely, a significantly higher percentage of embryos from patients in the Day 5 group received an 'A' score of the ICM (76.8 vs. 59.0%) and TE (71.6 vs. 62.0%) compared with embryos from patients in the Day 6 group. With regard to cycle outcome, patients in the Day 5 group had significantly better clinical outcome in terms of more embryos frozen and a higher biochemical and clinical pregnancy rate compared with patients in the Day 6 group ( Categorical variables are presented as n (%) and compared using as χ 2 test. Mean ± SD and range are presented for continuous normal distributed variables that were compared using t-test. Continuous non-normal distributed data are presented as median (range) and compared using Wilcoxon Rank-Sum test. *P-value < 0.05.
The univariable logistic regression analysis identified maternal age, BMI, cumulative FSH dose, number of cryopreserved embryos, blastocyst quality (BQ) on both Day 5 and day of transfer as predictors of clinical pregnancy (Table II) . As BQ on Day 5 and BQ on day of transfer are dependent variables, only BQ on day of transfer was selected for the multivariate analysis. The unadjusted odds ratio for implantation between Day 5 and Day 6 groups was 0.35 (0.25-0.49). After adjusting for age, BMI, cumulative FSH dose, number of cryopreserved embryos and BQ on day of transfer in a multivariable logistic regression analysis, only the day of transfer remained significant (Table III) . Thus, the adjusted odds ratio for implantation after transfer on Day 6 transfer was significantly lower than after transfer on Day 5 (OR 0.34; 95% CI 0.22-0.52).
Discussion
The present study of clinical pregnancy following transfer of normally developing single blastocysts on Day 5 or 6 strongly suggests that the chance of implantation is reduced to 1/3 if transfer of blastocysts is postponed to Day 6. While the study provides no definitive answers regarding the specific cause of the reduced IR on Day 6, the reduction is substantial and clinically relevant, which should cause clinics to consider cryopreservation after Day 5 rather than fresh Day 6 transfers. As several clinics routinely allow for fresh transfer of normally developing embryos on Day 6 for logistical reasons such as limitations in opening hours or incoming PGS/PGD results, changing strategy towards systematic cryopreservation may likely result in improved pregnancy rates.
Previous studies have reported higher IRs with normally developing blastocysts transferred on Day 5 compared to blastocysts with delayed development causing postponed transferral to Day 6 (Khorram et al., 2000; Shapiro et al., 2001; Barrenetxea et al., 2005) . In such studies, the low IRs observed after Day 6 transfers have traditionally been explained by impaired embryo quality as embryos that are slower to progress have been reported as chromosomal abnormal (Taylor et al., 2014) , although this relation has recently been questioned (Capalbo et al., 2014) . Regardless, many confounding factors potentially differ between the groups, when clinical outcome is compared between blastocysts with normal development and blastocysts with delayed development. Specifically, the contribution from the potentially less receptive endometrium on Day 6 has not been evaluated. In the present study, the decision to transfer on Day 5 or 6 was based entirely on logistics. By design, the major variables to differ between the two patient groups are therefore in principle prolonged culture and endometrial receptivity. Our findings quite clearly demonstrate that the patients, who by chance had the blastocyst transferred on Day 5, had a significant and clinically relevant higher chance of pregnancy, than patients, who by chance received the transfer on Day 6.
In contrast, very little data are available on the outcome after elective Day 6 transfer. Elgindy and Elsedeek (2012) evaluated the question using a study design similar to ours (Elgindy and Elsedeek, 2012) . Expanded blastocysts were randomized to transfer on Day 5 and Day 6, while a third group of blastocysts with delayed expansion were transferred on Day 6. In contrast to our study, IRs were similar in the two groups of normally developing expanded blastocysts transferred on Day 5 (174 cases, 40%) and Day 6 (25 cases, 40%), respectively, which led the authors to conclude that elective Day 5 and Day 6 transfers have comparable outcome. However, the small numbers in the latter group indicate that the study was not sufficiently powered to draw this conclusion.
While our study does not allow us to conclude on whether the reduced implantation potential is caused by prolonged culture or decreased endometrial receptivity, studies on cryopreserved blastocysts suggest a major contribution from the embryo-endometrium interaction. These studies reported similar pregnancy rates for blastocysts expanding and cryopreserved on Day 5 and Day 6, with subsequent transfer in a hormone substituted cycle (Behr et al., 2002; Richter et al., 2006) suggesting that the day of transfer is more important to the IR than the day of expansion. The authors of a large metaanalysis on cryopreserved blastocysts concluded that the lower IR achieved by Day 6 transfers may be due to decreased endometrial receptivity and not to a lower embryo quality (Sunkara et al., 2010) .
On the other hand, we cannot exclude that the extended culture may have a negative impact on otherwise normally developing embryos, which may contribute to the observed reduced IRs. Degree of expansion along with TE and ICM scores are known important predictors for implantation (Kovacic et al., 2004; Ahlstrom et al., 2011; Alpha Scientists, 2011; Basile et al., 2015) although the relation to clinical outcome has been evaluated primarily on data obtained on Day 5. Obviously, degree of expansion cannot be compared directly between Day 5 and Day 6 embryos, given the 24-h longer incubation of embryos in the Day 6 group. The longer incubation time is, however, adjusted for when categorizing embryos in high, medium and low quality, where a higher degree of expansion (4 vs. 3) is required to achieve a high quality score on Day 6. Our univariable logistic regression analysis none-the-less revealed a significantly higher percentage of high quality embryos from patients in the Day 5 group compared with embryos from patients in the Day 6 group. Although it is poorly described whether morphology scores primarily developed on Day 5 blastocysts are directly applicable to Day 6 embryos in terms of quality and implantation potential, it may be speculated that embryos thrive less in vitro under our culture conditions after reaching the blastocyst stage if not transferred (Levens et al., 2008; Shahbazi et al., 2016) . We therefore compared blastocyst score on Day 5 for both groups. As can be seen in Supplementary Table SI, there was no difference in mean degree of expansion between the groups, while the exact score of expansion and score of TE and ICM were significantly different between the groups on Day 5. Embryo score on Day 5 for Day 6 embryos was obtained from the EmbryoViewer, as embryos were not removed from the incubator before transfer, while the score on day of transfer was obtained under a standard light microscope, which may influence the comparison. Furthermore, the embryos were chosen based on score on the day of transfer, which means that the embryo with the highest score on Day 6 did not necessarily have the highest score the day before. Finally, Day 6 transfers were mainly performed in the first period, which was a study period where blastocyst transfers were offered only as part of a study, which could cause selection bias. The similar pregnancy rates of Day 5 and Day 6 in the analysis of pregnancy rates stratified on time periods (Supplemental Table SII) suggest that this potential bias is of minor influence. However, if we assume that the findings represent a true difference, it would bias the results in favour of Day 5 transfer. Importantly, when adjusting for potential confounders, including BQ on the day of transfer, the influence of day of transfer on clinical outcome remained highly significant.
Apart from the above-mentioned parameters, the only difference in our baseline data was a higher number of previous cycles in the Day 6 group compared with women who had transfers performed on Day 5. We found that the difference was not related to the clinical pregnancy rate in our univariable logistic regression analysis, which suggests that the two groups were comparable.
In the current study, the selection of patients, laboratory methods, media and methods of blastocyst transfer was consistent over the time of data collection, while the default transfer day differed in the two periods of time. From 2011 until 2013, the preferred day of transfer was Day 6; Day 5 transfers only occurred when Day 6 was a Sunday. Subsequently, from 2013 until 2015, the preferred day of transfer was Day 5; Day 6 transfers only occurred when Day 5 was a Sunday. A subanalysis stratifying the two time periods shows no difference in IRs for neither Day 6 nor Day 5 transfers according to time periods (Supplementary Table SII) . Therefore, we conclude that these differences may cause a minor variation in the data, but hardly enough to explain our main conclusions, as the odds for implantation are substantially lower for normally developing blastocysts transferred on Day 6 compared with Day 5. In contrast, the narrow CI, which reflects the large sample size, and the strength of the multivariable logistic regression analysis as reflected by the magnitude of the adjusted OR, suggests a true difference. Although a properly designed randomized study would be needed to obtain conclusive evidence, the present results with a highly clinically relevant reduction may render it ethically difficult to accept strict randomization between Day 5 and Day 6 transfer.
In conclusion, our study demonstrates that elective blastocyst transfer performed on Day 6 has significantly lower IRs than transfer performed on Day 5. Based on our findings, we therefore strongly recommend that normally developing blastocysts should be transferred on cycle Day 5. Thus, if transfer on Day 5 is logistically impossible to perform, cryopreservation and later transfer in a natural or artificial cycle should be preferred.
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